#begin document (wsj_1938.en); part 000
wsj_1938.en	0	0	Ciba-Geigy	NNP	*	_	_	2	_	(1|(4
wsj_1938.en	0	1	Ltd.	NNP	*	_	_	3	_	4)
wsj_1938.en	0	2	and	CC	*	_	_	6	_	-
wsj_1938.en	0	3	Chiron	NNP	*	_	_	5	_	(5
wsj_1938.en	0	4	Corp.	NNP	*	_	_	3	_	1)|5)
wsj_1938.en	0	5	said	VBD	*	_	_	0	_	-
wsj_1938.en	0	6	they	PRP	*	_	_	8	_	(1)
wsj_1938.en	0	7	extended	VBD	*	_	_	6	_	-
wsj_1938.en	0	8	their	PRP$	*	_	_	10	_	(1)|(2
wsj_1938.en	0	9	offer	NN	*	_	_	8	_	-
wsj_1938.en	0	10	for	IN	*	_	_	10	_	-
wsj_1938.en	0	11	Connaught	NNP	*	_	_	13	_	(3
wsj_1938.en	0	12	BioSciences	NNP	*	_	_	14	_	-
wsj_1938.en	0	13	Inc.	NNP	*	_	_	11	_	3)
wsj_1938.en	0	14	,	,	*	_	_	10	_	-
wsj_1938.en	0	15	valued	VBN	*	_	_	10	_	-
wsj_1938.en	0	16	at	IN	*	_	_	16	_	-
wsj_1938.en	0	17	866	CD	*	_	_	19	_	-
wsj_1938.en	0	18	million	CD	*	_	_	21	_	-
wsj_1938.en	0	19	Canadian	JJ	*	_	_	21	_	-
wsj_1938.en	0	20	dollars	NNS	*	_	_	17	_	-
wsj_1938.en	0	21	-LRB-	-LRB-	*	_	_	25	_	-
wsj_1938.en	0	22	US$	$	*	_	_	25	_	-
wsj_1938.en	0	23	736	CD	*	_	_	25	_	-
wsj_1938.en	0	24	million	CD	*	_	_	21	_	-
wsj_1938.en	0	25	-RRB-	-RRB-	*	_	_	25	_	2)
wsj_1938.en	0	26	to	TO	*	_	_	8	_	-
wsj_1938.en	0	27	Oct.	NNP	*	_	_	27	_	-
wsj_1938.en	0	28	27	CD	*	_	_	28	_	-
wsj_1938.en	0	29	.	.	*	_	_	6	_	-

wsj_1938.en	0	0	The	DT	*	_	_	32	_	(1
wsj_1938.en	0	1	companies	NNS	*	_	_	34	_	1)
wsj_1938.en	0	2	earlier	RBR	*	_	_	34	_	-
wsj_1938.en	0	3	said	VBD	*	_	_	0	_	-
wsj_1938.en	0	4	they	PRP	*	_	_	38	_	(1)
wsj_1938.en	0	5	did	VBD	*	_	_	38	_	-
wsj_1938.en	0	6	n't	RB	*	_	_	38	_	-
wsj_1938.en	0	7	want	VB	*	_	_	34	_	-
wsj_1938.en	0	8	to	TO	*	_	_	38	_	-
wsj_1938.en	0	9	raise	VB	*	_	_	39	_	-
wsj_1938.en	0	10	their	PRP$	*	_	_	42	_	(1)|(2
wsj_1938.en	0	11	offer	NN	*	_	_	40	_	2)
wsj_1938.en	0	12	to	TO	*	_	_	40	_	-
wsj_1938.en	0	13	match	VB	*	_	_	43	_	-
wsj_1938.en	0	14	a	DT	*	_	_	47	_	-
wsj_1938.en	0	15	rival	JJ	*	_	_	47	_	-
wsj_1938.en	0	16	bid	NN	*	_	_	44	_	-
wsj_1938.en	0	17	by	IN	*	_	_	47	_	-
wsj_1938.en	0	18	Institut	NNP	*	_	_	50	_	(6
wsj_1938.en	0	19	Merieux	NNP	*	_	_	51	_	-
wsj_1938.en	0	20	S.A.	NNP	*	_	_	48	_	6)
wsj_1938.en	0	21	of	IN	*	_	_	47	_	-
wsj_1938.en	0	22	C$	$	*	_	_	56	_	-
wsj_1938.en	0	23	37	CD	*	_	_	53	_	-
wsj_1938.en	0	24	a	DT	*	_	_	56	_	-
wsj_1938.en	0	25	share	NN	*	_	_	58	_	-
wsj_1938.en	0	26	,	,	*	_	_	58	_	-
wsj_1938.en	0	27	or	CC	*	_	_	52	_	-
wsj_1938.en	0	28	C$	$	*	_	_	61	_	-
wsj_1938.en	0	29	942	CD	*	_	_	61	_	-
wsj_1938.en	0	30	million	CD	*	_	_	58	_	-
wsj_1938.en	0	31	.	.	*	_	_	34	_	-

wsj_1938.en	0	0	But	CC	*	_	_	65	_	-
wsj_1938.en	0	1	they	PRP	*	_	_	65	_	(1)
wsj_1938.en	0	2	said	VBD	*	_	_	0	_	-
wsj_1938.en	0	3	the	DT	*	_	_	69	_	(2
wsj_1938.en	0	4	C$	$	*	_	_	68	_	-
wsj_1938.en	0	5	30-a-share	JJ	*	_	_	69	_	-
wsj_1938.en	0	6	bid	NN	*	_	_	82	_	-
wsj_1938.en	0	7	,	,	*	_	_	69	_	2)
wsj_1938.en	0	8	which	WDT	*	_	_	72	_	(2)
wsj_1938.en	0	9	was	VBD	*	_	_	69	_	-
wsj_1938.en	0	10	due	JJ	*	_	_	72	_	-
wsj_1938.en	0	11	to	TO	*	_	_	73	_	-
wsj_1938.en	0	12	expire	VB	*	_	_	74	_	-
wsj_1938.en	0	13	Monday	NNP	*	_	_	75	_	-
wsj_1938.en	0	14	,	,	*	_	_	69	_	-
wsj_1938.en	0	15	may	MD	*	_	_	82	_	-
wsj_1938.en	0	16	still	RB	*	_	_	82	_	-
wsj_1938.en	0	17	be	VB	*	_	_	82	_	-
wsj_1938.en	0	18	extended	VBN	*	_	_	82	_	-
wsj_1938.en	0	19	or	CC	*	_	_	65	_	-
wsj_1938.en	0	20	varied	VBN	*	_	_	82	_	-
wsj_1938.en	0	21	.	.	*	_	_	65	_	-

wsj_1938.en	0	0	Merieux	NNP	*	_	_	86	_	(6)
wsj_1938.en	0	1	,	,	*	_	_	96	_	-
wsj_1938.en	0	2	a	DT	*	_	_	89	_	(6
wsj_1938.en	0	3	vaccine	NN	*	_	_	89	_	-
wsj_1938.en	0	4	manufacturer	NN	*	_	_	86	_	6)
wsj_1938.en	0	5	based	VBN	*	_	_	89	_	-
wsj_1938.en	0	6	in	IN	*	_	_	90	_	-
wsj_1938.en	0	7	Lyon	NNP	*	_	_	94	_	-
wsj_1938.en	0	8	,	,	*	_	_	94	_	-
wsj_1938.en	0	9	France	NNP	*	_	_	91	_	(7)
wsj_1938.en	0	10	,	,	*	_	_	94	_	-
wsj_1938.en	0	11	is	VBZ	*	_	_	0	_	-
wsj_1938.en	0	12	51%-held	JJ	*	_	_	96	_	-
wsj_1938.en	0	13	by	IN	*	_	_	97	_	-
wsj_1938.en	0	14	French	JJ	*	_	_	102	_	-
wsj_1938.en	0	15	state-owned	JJ	*	_	_	102	_	(7)
wsj_1938.en	0	16	Rhone-Poulenc	NNP	*	_	_	102	_	-
wsj_1938.en	0	17	S.A	NNP	*	_	_	98	_	-
wsj_1938.en	0	18	.	.	*	_	_	96	_	-

wsj_1938.en	0	0	Ciba-Geigy	NNP	*	_	_	105	_	(4)
wsj_1938.en	0	1	is	VBZ	*	_	_	0	_	-
wsj_1938.en	0	2	a	DT	*	_	_	109	_	(8
wsj_1938.en	0	3	major	JJ	*	_	_	109	_	-
wsj_1938.en	0	4	pharmaceutical	JJ	*	_	_	109	_	-
wsj_1938.en	0	5	concern	NN	*	_	_	105	_	8)
wsj_1938.en	0	6	based	VBN	*	_	_	109	_	-
wsj_1938.en	0	7	in	IN	*	_	_	110	_	-
wsj_1938.en	0	8	Basel	NNP	*	_	_	114	_	-
wsj_1938.en	0	9	,	,	*	_	_	114	_	-
wsj_1938.en	0	10	Switzerland	NNP	*	_	_	111	_	-
wsj_1938.en	0	11	.	.	*	_	_	105	_	-

wsj_1938.en	0	0	Chiron	NNP	*	_	_	117	_	(5)
wsj_1938.en	0	1	,	,	*	_	_	123	_	-
wsj_1938.en	0	2	another	DT	*	_	_	120	_	(5
wsj_1938.en	0	3	pharmaceutical	JJ	*	_	_	120	_	-
wsj_1938.en	0	4	concern	NN	*	_	_	117	_	5)
wsj_1938.en	0	5	,	,	*	_	_	120	_	-
wsj_1938.en	0	6	is	VBZ	*	_	_	123	_	-
wsj_1938.en	0	7	based	VBN	*	_	_	0	_	-
wsj_1938.en	0	8	in	IN	*	_	_	123	_	-
wsj_1938.en	0	9	Emeryville	NNP	*	_	_	127	_	-
wsj_1938.en	0	10	,	,	*	_	_	127	_	-
wsj_1938.en	0	11	Calif	NNP	*	_	_	124	_	-
wsj_1938.en	0	12	.	.	*	_	_	123	_	-

wsj_1938.en	0	0	Connaught	NNP	*	_	_	130	_	(3)
wsj_1938.en	0	1	is	VBZ	*	_	_	0	_	-
wsj_1938.en	0	2	a	DT	*	_	_	137	_	-
wsj_1938.en	0	3	biotechnology	NN	*	_	_	133	_	-
wsj_1938.en	0	4	research	NN	*	_	_	134	_	-
wsj_1938.en	0	5	and	CC	*	_	_	137	_	-
wsj_1938.en	0	6	vaccine	NN	*	_	_	134	_	-
wsj_1938.en	0	7	manufacturing	NN	*	_	_	134	_	-
wsj_1938.en	0	8	concern	NN	*	_	_	130	_	-
wsj_1938.en	0	9	.	.	*	_	_	130	_	-

wsj_1938.en	0	0	Institut	NNP	*	_	_	140	_	(6
wsj_1938.en	0	1	Merieux	NNP	*	_	_	142	_	-
wsj_1938.en	0	2	's	POS	*	_	_	140	_	6)
wsj_1938.en	0	3	bid	NN	*	_	_	147	_	-
wsj_1938.en	0	4	for	IN	*	_	_	142	_	-
wsj_1938.en	0	5	Toronto-based	JJ	*	_	_	145	_	(3
wsj_1938.en	0	6	Connaught	NNP	*	_	_	143	_	3)
wsj_1938.en	0	7	has	VBZ	*	_	_	147	_	-
wsj_1938.en	0	8	run	VBN	*	_	_	0	_	-
wsj_1938.en	0	9	into	IN	*	_	_	147	_	-
wsj_1938.en	0	10	problems	NNS	*	_	_	148	_	-
wsj_1938.en	0	11	with	IN	*	_	_	149	_	-
wsj_1938.en	0	12	the	DT	*	_	_	153	_	(9
wsj_1938.en	0	13	Canadian	JJ	*	_	_	153	_	-
wsj_1938.en	0	14	government	NN	*	_	_	150	_	9)
wsj_1938.en	0	15	,	,	*	_	_	153	_	-
wsj_1938.en	0	16	which	WDT	*	_	_	156	_	(9)|(10
wsj_1938.en	0	17	told	VBD	*	_	_	153	_	-
wsj_1938.en	0	18	Merieux	NNP	*	_	_	156	_	(6)
wsj_1938.en	0	19	last	JJ	*	_	_	159	_	-
wsj_1938.en	0	20	week	NN	*	_	_	156	_	-
wsj_1938.en	0	21	that	IN	*	_	_	156	_	-
wsj_1938.en	0	22	it	PRP	*	_	_	164	_	(9)
wsj_1938.en	0	23	was	VBD	*	_	_	164	_	-
wsj_1938.en	0	24	n't	RB	*	_	_	164	_	-
wsj_1938.en	0	25	convinced	VBN	*	_	_	160	_	-
wsj_1938.en	0	26	that	IN	*	_	_	164	_	-
wsj_1938.en	0	27	the	DT	*	_	_	168	_	-
wsj_1938.en	0	28	proposed	JJ	*	_	_	168	_	-
wsj_1938.en	0	29	acquisition	NN	*	_	_	169	_	-
wsj_1938.en	0	30	would	MD	*	_	_	165	_	-
wsj_1938.en	0	31	be	VB	*	_	_	169	_	-
wsj_1938.en	0	32	of	IN	*	_	_	170	_	-
wsj_1938.en	0	33	``	``	*	_	_	174	_	-
wsj_1938.en	0	34	net	JJ	*	_	_	174	_	-
wsj_1938.en	0	35	benefit	NN	*	_	_	171	_	-
wsj_1938.en	0	36	''	''	*	_	_	174	_	-
wsj_1938.en	0	37	to	TO	*	_	_	174	_	-
wsj_1938.en	0	38	Canada	NNP	*	_	_	176	_	10)
wsj_1938.en	0	39	.	.	*	_	_	147	_	-

wsj_1938.en	0	0	Merieux	NNP	*	_	_	180	_	(6)|(12
wsj_1938.en	0	1	officials	NNS	*	_	_	182	_	12)
wsj_1938.en	0	2	are	VBP	*	_	_	182	_	-
wsj_1938.en	0	3	expected	VBN	*	_	_	0	_	-
wsj_1938.en	0	4	to	TO	*	_	_	182	_	-
wsj_1938.en	0	5	meet	VB	*	_	_	183	_	-
wsj_1938.en	0	6	with	IN	*	_	_	184	_	-
wsj_1938.en	0	7	federal	JJ	*	_	_	187	_	(11
wsj_1938.en	0	8	officials	NNS	*	_	_	185	_	11)
wsj_1938.en	0	9	in	IN	*	_	_	184	_	-
wsj_1938.en	0	10	Ottawa	NNP	*	_	_	188	_	-
wsj_1938.en	0	11	today	NN	*	_	_	184	_	-
wsj_1938.en	0	12	to	TO	*	_	_	184	_	-
wsj_1938.en	0	13	discuss	VB	*	_	_	191	_	-
wsj_1938.en	0	14	the	DT	*	_	_	194	_	(10
wsj_1938.en	0	15	decision	NN	*	_	_	192	_	10)
wsj_1938.en	0	16	.	.	*	_	_	182	_	-

#end document 